Literature DB >> 29796044

Steroids in the Management of Synkinesis after Traumatic Oculomotor Palsy in India.

Peter W MacIntosh1, Virna Shah2.   

Abstract

Traumatic oculomotor nerve palsies may result in aberrant regeneration and synkinesis that can impair normal facial function. We retrospectively investigated 16 patients with traumatic oculomotor nerve palsies who were treated with and without steroids to evaluate the rates of aberrant regeneration. The overall rates of aberrant regeneration were similar between the two groups and in line with other published series. Some limitations to our study may limit our ability to detect real differences, and additional studies would be beneficial.

Entities:  

Keywords:  Aberrant regeneration; oculomotor nerve; steroids; synkinesis; trauma

Year:  2017        PMID: 29796044      PMCID: PMC5958956          DOI: 10.1080/01658107.2017.1370654

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  12 in total

1.  Direct injury of the oculomotor nerve in craniocerebral trauma.

Authors:  M Y Memon; K W Paine
Journal:  J Neurosurg       Date:  1971-10       Impact factor: 5.115

2.  Aberrant regeneration of the inferior division of the oculomotor nerve.

Authors:  R H Spector; M A Faria
Journal:  Arch Neurol       Date:  1981-07

Review 3.  Third nerve palsies.

Authors:  Beau B Bruce; Valérie Biousse; Nancy J Newman
Journal:  Semin Neurol       Date:  2007-07       Impact factor: 3.420

4.  Efficiency of corticosteroid treatment in resolution of bilateral abducens paralysis after head trauma.

Authors:  Umit Taskin; Ozgur Yigit; A Sezim Sisman; Sahin Ogreden; Engin Acioglu; Kadir Eltutar
Journal:  J Craniofac Surg       Date:  2009-11       Impact factor: 1.046

5.  Direct traumatic third nerve palsy.

Authors:  N B Solomons; D J Solomon; J C de Villiers
Journal:  S Afr Med J       Date:  1980-07-19

6.  Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial.

Authors:  Ian Roberts; David Yates; Peter Sandercock; Barbara Farrell; Jonathan Wasserberg; Gabrielle Lomas; Rowland Cottingham; Petr Svoboda; Nigel Brayley; Guy Mazairac; Véronique Laloë; Angeles Muñoz-Sánchez; Miguel Arango; Bennie Hartzenberg; Hussein Khamis; Surakrant Yutthakasemsunt; Edward Komolafe; Fatos Olldashi; Yadram Yadav; Francisco Murillo-Cabezas; Haleema Shakur; Phil Edwards
Journal:  Lancet       Date:  2004 Oct 9-15       Impact factor: 79.321

7.  Aberrant regeneration of the oculomotor nerve: implications for neurosurgeons.

Authors:  Eric D Weber; Steven A Newman
Journal:  Neurosurg Focus       Date:  2007       Impact factor: 4.047

8.  Early treatment with prednisolone or acyclovir in Bell's palsy.

Authors:  Frank M Sullivan; Iain R C Swan; Peter T Donnan; Jillian M Morrison; Blair H Smith; Brian McKinstry; Richard J Davenport; Luke D Vale; Janet E Clarkson; Victoria Hammersley; Sima Hayavi; Anne McAteer; Ken Stewart; Fergus Daly
Journal:  N Engl J Med       Date:  2007-10-18       Impact factor: 91.245

9.  Clinical features and functional recovery of traumatic isolated oculomotor nerve palsy in mild head injury with sphenoid fracture.

Authors:  Chao Lin; Yan Dong; Liquan Lv; Mingkun Yu; Lijun Hou
Journal:  J Neurosurg       Date:  2012-11-02       Impact factor: 5.115

10.  [Successful steroid pulse therapy for acute unilateral oculomotor nerve palsy associated with norovirus infection].

Authors:  Ichiro Kuki; Hisashi Kawawaki; Shin Okazaki; Hiroko Ikeda; Kiyotaka Tomiwa
Journal:  No To Hattatsu       Date:  2008-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.